Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 08 06 2020
revised: 27 10 2020
accepted: 19 11 2020
pubmed: 8 1 2021
medline: 3 2 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

It is important to quantify the true burden of coronavirus disease 2019 (COVID-19) in different countries, to enable informed decisions about imposing and relaxing control measures. COVID-19 surveillance data fails in this respect, as it is influenced by different definitions, control policies and capacities. This article aims to quantify excess mortality and estimate the distribution between COVID-19 and non-COVID-19 causes of death. Observational study and mathematical modelling. Publicly available data from multiple institutional sources were used and an in-depth analysis was carried out of deaths from all causes between 2015 and 2020 in Italy at the national, regional and local level. Excess mortality over time and space was first explored, followed by an assessment of how this related to COVID-19 surveillance and, ultimately, assuming a fixed male:female ratio, a model was developed and applied to estimate the proportions of COVID-19 and non-COVID-19 excess mortality in 2020. In Italy, the mortality rate doubled in March and April 2020 compared with data from 2015 to 2019 (+109%, when considering municipalites with >10.000 inhabitants), with excess mortality reaching >600% in large municipalities in northern areas. Notified COVID-19 deaths accounted for only 43.5% (regional range: 43-62%) of excess mortality. It is estimated that more than two-thirds of excess deaths that were not captured by surveillance are non-COVID-19 deaths, which could be a result of the excess burden on the health systems, in addition to reduced demand and supply of other non-COVID healthcare services. The impact of COVID-19 during the early stages of the pandemic is much larger than official figures have reported. Monitoring excess mortality helps to capture the full effect of the COVID-19 pandemic, which differs between regions in Italy and which might have resulted in significant indirect effects on the well-being of the population. In addition, the COVID-19 pandemic has also resulted in significant indirect effects on the well-being of the population.

Identifiants

pubmed: 33412438
pii: S0033-3506(20)30504-7
doi: 10.1016/j.puhe.2020.11.016
pmc: PMC7703200
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-115

Informations de copyright

Copyright © 2020 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Références

N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e350-e351
pubmed: 32339340
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605
pubmed: 32407306
Euro Surveill. 2020 May;25(19):
pubmed: 32431289
Lancet. 2020 Apr 11;395(10231):1168
pubmed: 32278370
Neurosurgery. 2020 Aug 1;87(2):E211
pubmed: 32355982
J Infect. 2020 Nov;81(5):797-801
pubmed: 32956730
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
J Infect. 2020 Nov;81(5):785-792
pubmed: 32858068
Lancet. 2020 Jun 13;395(10240):1829
pubmed: 32473099
PLoS One. 2020 Oct 9;15(10):e0240286
pubmed: 33035253
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413
pubmed: 32791953
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Int J Antimicrob Agents. 2020 Jun;55(6):106006
pubmed: 32371096
Lancet. 2020 May 2;395(10234):e81
pubmed: 32333839
ERJ Open Res. 2020 Sep 28;6(3):
pubmed: 33015145
Lancet Public Health. 2020 Jun;5(6):e310
pubmed: 32339478
BMJ. 2020 May 14;369:m1835
pubmed: 32409488
Cien Saude Colet. 2020 Sep;25(9):3345-3354
pubmed: 32876246
Am J Clin Pathol. 2021 Jan 4;155(1):64-68
pubmed: 32995855
BMJ. 2020 Apr 14;369:m1484
pubmed: 32291254
J Epidemiol Glob Health. 2020 Sep;10(3):209-213
pubmed: 32954711
N Engl J Med. 2020 Jul 23;383(4):400-401
pubmed: 32383831
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Lancet Public Health. 2020 Aug;5(8):e437-e443
pubmed: 32473113
BMJ. 2020 Apr 24;369:m1607
pubmed: 32332059
Front Med (Lausanne). 2020 Jul 14;7:402
pubmed: 32766267

Auteurs

A Odone (A)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy. Electronic address: anna.odone@unipv.it.

D Delmonte (D)

Italian National Research Council - IMEM, Parma, Italy.

G Gaetti (G)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

C Signorelli (C)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH